Haemoglobin monitoring in anaemia of CKD
every 1 to 3 months in the maintenance phase of ESA therapy
tests per year, UK, every 1 to 3 months in the maintenance phase of ESA therapy (every 2 to 4 weeks during induction)
“In adults, children and young people with anaemia of CKD, monitor Hb: every 2 to 4 weeks in the induction phase of ESA therapy every 1 to 3 months in the maintenance phase of ESA therapy”
NICE NG203, Chronic kidney disease: assessment and management, section 1.1, 2021-08
- Kind of source
- Clinical guideline
- Read on
- 2026-11-06
- Daily check
- Quote found at the source on 2026-11-06
- What to know
- Applies to people with CKD who develop anaemia and take erythropoiesis-stimulating agents. 4 to 12 tests a year is every 3 months to every month.
Used in
Kept as evidence; no figure on the platform is computed from it yet.